Dalis, Jayther T.
HRN: 14-32-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2023
CEFAZOLIN 1GM (VIAL)
07/06/2023
07/12/2023
IVT
1g
Q8
T/c Transurethral Injury Sec To VA
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes